Skip to content
LATEST
Health

Genetic Profile Linked to 70% Lower Dementia Risk with Low-Dose Aspirin

A specific genetic profile may allow for a 70% reduction in dementia risk via low-dose aspirin, though this benefit is offset by a significant increase in…

Genetic Profile Linked to 70% Lower Dementia Risk with Low-Dose Aspirin

A recent analysis of clinical trial data indicates that low-dose aspirin is associated with a 70% reduction in dementia risk among older adults possessing a specific genetic profile related to platelet count. This finding suggests that genetic stratification may be necessary to identify populations that derive therapeutic benefit from aspirin, as previous broad-based studies showed no overall protective effect.

However, the data reveals a significant clinical trade-off for this specific genetic subgroup. Aspirin users within this cohort experienced a major bleeding rate of 4.4%, compared to 2.1% for those receiving a placebo, indicating a heightened risk of adverse hemorrhagic events.

Researchers emphasize that these findings are preliminary and require validation through targeted clinical trials before informing medical guidelines. The study highlights the potential for personalized medicine in dementia prevention but warns against the prophylactic use of aspirin without clinical supervision due to the documented safety risks.

More stories

Latest news